Ramesh Juneja For and on behalf of Promoters and Promoter Group of the Company has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ramesh Juneja, acting on behalf of the promoters and promoter group of Mankind Pharma, has submitted a disclosure to NSE under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires promoters to periodically disclose details of their encumbered (pledged) shares held in the company. The filing is a routine compliance submission regarding the encumbrance status of promoter holdings and does not, on its face, indicate any specific transaction, change in pledge levels, or movement in promoter shareholding. No detailed figures on pledge percentage, invocation, release, or stake change have been provided in the headline.
This appears to be a standard regulatory compliance filing rather than an actionable event. Shareholders need not react immediately, but should watch for the detailed disclosure to confirm whether there has been any change in pledged shares or promoter encumbrance levels.